샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514246

세계의 호르몬 대체요법(HRT) 시장

Hormone Replacement Therapy (HRT)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 호르몬 대체요법(HRT) 시장은 2030년까지 446억 달러에 이를 것으로 예상

2023년에 293억 달러로 평가된 세계의 호르몬 대체요법(HRT) 시장은 분석 기간 2023년부터 2030년까지 CAGR 6.2%로 성장할 전망이며, 2030년에는 446억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 에스트로겐 호르몬 대체요법은 CAGR 6.3%로 성장을 지속하고, 분석 기간 종료 시 242억 달러에 달할 것으로 예측됩니다. 인간 성장 호르몬 대체요법 분야의 성장률은 분석 기간 동안 CAGR 7.4%로 추정됩니다.

미국 시장은 78억 달러로 추정, 중국은 CAGR 5.8%로 성장 예측

미국의 호르몬 대체요법(HRT) 시장은 2023년 78억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 70억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 5.8%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.6%와 5.1%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 것으로 예측됩니다.

호르몬 대체요법(HRT)-주요 동향 및 촉진요인

호르몬 대체요법(HRT)은 호르몬 균형의 혼란과 결핍과 관련된 증상, 특히 여성의 갱년기 장애와 관련된 증상을 완화하는 데 사용되는 치료법입니다. HRT는 에스트로겐, 황체 호르몬, 때로는 테스토스테론과 같은 호르몬을 투여하여 호르몬 수치를 회복시키고, 홍조, 땀, 기분 저하, 질 건조 등의 증상을 완화시킵니다. HRT는 경구 정제, 경피 패치, 겔, 크림, 주사제 등 다양한 형태로 투여됩니다. 이 치료법은 폐경 증상을 관리하는 데 도움이 될뿐만 아니라 골다공증을 예방하고 삶의 질을 향상시키는 데 도움이 됩니다. 그러나 HRT를 받는지 여부는 혈전, 뇌졸중, 특정 암의 가능성이 높아지는 등의 잠재적 위험이 있기 때문에 의료 제공업체에 의해 신중하게 평가되어야 하며 치료에 개별화된 접근법이 필요합니다.

현재 의학 연구의 진보와 환자 선호의 변화를 반영하여 일부 동향은 HRT의 상황을 형성하고 있습니다. 주목할 만한 동향 중 하나는 바이오 아이덴티컬 호르몬의 개발입니다. 바이오 아이덴티컬 호르몬은 인체에서 자연적으로 생성되는 호르몬과 화학적으로 동일합니다. 이 바이오 아이덴티컬 호르몬은 기존의 합성 호르몬을 대체하는보다 자연스럽고 안전한 옵션을 제공하는 것으로 생각되며 환자와 건강 관리 제공업체 모두에게 관심이 높아지고 있습니다. 게다가, 개인화된 의료가 중요해지고 있으며, HRT 치료는 유전적, 호르몬적, 라이프스타일 요인에 기초하여 개별 환자 프로파일에 맞게 조정됩니다. 이 접근법은 위험을 최소화하면서 치료 효과를 극대화하고 환자 결과를 개선하는 것을 목표로 합니다. 기술의 진보로 HRT의 투여방법도 강화되고 있으며, 호르몬 임플란트나 고도의 경피흡수 시스템 등의 혁신적 기술에 의해 호르몬 농도가 보다 안정되고 환자의 편의성도 향상하고 있습니다.

호르몬 대체요법(HRT) 시장의 성장은 여러 요인에 의해 발생합니다. 의약품 제형 및 전달 시스템의 기술적 진보는 HRT의 효능과 안전성을 향상시키고 호르몬 균형의 혼란을 관리하는 매력적인 선택입니다. 노인 여성 인구에서 폐경 증상의 유병률이 증가하면 HRT 치료에 대한 수요가 확대되고 있습니다. 또한, 삶의 질 향상과 골다공증 예방에서 HRT의 이점에 대한 의식이 높아짐에 따라 더 많은 여성들이 치료를 요구하도록 촉구하고 있습니다. 또한, 개인화된 의료 동향은 개별 환자의 특정 요구에 부합하는 맞춤형 HRT 요법의 개발을 촉진합니다. 바이오 아이덴티컬 호르몬을 사용할 수 있으며 이러한 자연 대체품에 대한 선호도가 증가하는 것은 시장 성장에 기여합니다. 또한 여성의 건강 증진을 목적으로 한 정부의 지원 정책과 이니셔티브가 HRT 채용을 촉진하고 있습니다. 이러한 요인이 결합되어 HRT 시장의 견조한 성장이 촉진되고 증가하는 환자 집단의 요구에 대응하고 호르몬 건강 관리 분야를 발전시키고 있습니다.

조사 대상 기업 예(총 47건)

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

AJY 24.07.24

Global Hormone Replacement Therapy (HRT) Market to Reach US$44.6 Billion by 2030

The global market for Hormone Replacement Therapy (HRT) estimated at US$29.3 Billion in the year 2023, is expected to reach US$44.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$24.2 Billion by the end of the analysis period. Growth in the Human Growth Hormone Replacement Therapy segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.8 Billion While China is Forecast to Grow at 5.8% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Hormone Replacement Therapy (HRT) - Key Trends and Drivers

Hormone Replacement Therapy (HRT) is a medical treatment used to alleviate symptoms associated with hormonal imbalances or deficiencies, particularly during menopause in women. HRT involves the administration of hormones such as estrogen, progesterone, and sometimes testosterone to restore hormonal levels and alleviate symptoms like hot flashes, night sweats, mood swings, and vaginal dryness. HRT can be delivered through various forms including oral tablets, transdermal patches, gels, creams, and injectable formulations. The therapy not only helps in managing menopausal symptoms but also provides benefits in preventing osteoporosis and improving quality of life. However, the decision to undergo HRT must be carefully evaluated by healthcare providers due to potential risks, such as increased chances of blood clots, stroke, and certain types of cancer, necessitating a personalized approach to treatment.

Several trends are currently shaping the HRT landscape, reflecting advancements in medical research and changing patient preferences. One notable trend is the development of bioidentical hormones, which are chemically identical to the hormones naturally produced by the human body. These bioidentical hormones are perceived to offer a more natural and potentially safer alternative to traditional synthetic hormones, attracting increasing interest from both patients and healthcare providers. Additionally, there is a growing emphasis on personalized medicine, with HRT treatments being tailored to individual patient profiles based on genetic, hormonal, and lifestyle factors. This approach aims to maximize the therapeutic benefits while minimizing risks, thereby improving patient outcomes. Technological advancements are also enhancing the delivery methods of HRT, with innovations such as hormone implants and advanced transdermal systems providing more consistent hormone levels and greater convenience for patients.

The growth in the Hormone Replacement Therapy (HRT) market is driven by several factors. Technological advancements in pharmaceutical formulations and delivery systems are enhancing the efficacy and safety of HRT, making it a more attractive option for managing hormonal imbalances. The increasing prevalence of menopausal symptoms among the aging female population is expanding the demand for HRT treatments. Moreover, the rising awareness about the benefits of HRT in improving quality of life and preventing osteoporosis is encouraging more women to seek treatment. Additionally, the trend towards personalized medicine is driving the development of customized HRT regimens that cater to the specific needs of individual patients. The availability of bioidentical hormones and the growing preference for these natural alternatives are also contributing to market growth. Furthermore, supportive government policies and initiatives aimed at improving women's health are facilitating the adoption of HRT. Collectively, these factors are fostering robust growth in the HRT market, addressing the needs of a growing patient population and advancing the field of hormonal health management.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Hormone Replacement Therapy (HRT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Menopausal Symptoms Propels Growth in HRT Market
    • Development of Bioidentical Hormones Expands Addressable Market Opportunity
    • Advancements in HRT Delivery Systems Strengthen Business Case for Modern Therapies
    • Growing Emphasis on Personalized Medicine Drives Adoption of Tailored HRT Regimens
    • Rising Awareness about Benefits of HRT Spurs Market Demand
    • Supportive Government Policies and Women's Health Initiatives Propel Market Growth
    • Innovations in Pharmaceutical Formulations Enhance Efficacy and Safety of HRT
    • Availability of Hormone Implants and Advanced Transdermal Systems Generates Demand
    • Increasing Life Expectancy and Aging Population Expands Addressable Market for HRT
    • Impact of Genetic and Lifestyle Factors on HRT Customization Generates Opportunities
    • Rising Focus on Preventing Osteoporosis through HRT Expands Market Reach
    • Advances in Diagnostic Tools and Hormone Level Monitoring Spur Growth in Personalized HRT
    • Growing Number of Clinical Studies and Research on HRT Safety and Efficacy
    • Increasing Patient Education and Awareness Campaigns Drive Demand for HRT
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hormone Replacement Therapy (HRT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Estrogen Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Human Growth Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Testosterone Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Thyroid Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Male Hypogonadism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Growth Hormone Deficiency by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hypothyroidism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Type of Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • JAPAN
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • CHINA
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • EUROPE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • FRANCE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • GERMANY
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제